By InvitationNot Applicable

Prospective Pilot Study Identifying Clinically Relevant Biological Targets for Medical Therapy

United States250 participantsStarted 2019-03-12

Plain-language summary

New data suggests that the current treatment for pediatric adamantinomatous craniopharyngioma (CPA) may not be as effective as it could be.

Age range30 Days – 21 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✓. Patients between 0-21 years of age.
✓. Patients with the diagnosis or clinical suspicion of craniopharyngioma in whom planned clinical management will include tissue sampling.